2007
DOI: 10.1038/sj.bjc.6603588
|View full text |Cite
|
Sign up to set email alerts
|

Use of interfering RNA to investigate the role of endogenous gastrin in the survival of gastrointestinal cancer cells

Abstract: Gastrin isoforms, acting through a variety of receptors, have proliferative and anti-apoptotic effects on gastrointestinal (GI) cancers. A small interfering RNA (siRNA) targeting the gastrin gene was used to investigate the role of endogenous gastrin in GI cancer cell survival. Downregulation of the gastrin gene in siRNA-transfected cells was measured using real-time reverse transcriptase -PCR. The most effective siRNA was tested in a panel of GI cancer cell lines at various concentrations and time points, and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
1

Year Published

2008
2008
2018
2018

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 19 publications
(13 citation statements)
references
References 41 publications
0
12
1
Order By: Relevance
“…A universal negative control siRNA was used as a negative control (Eurogentec, Southampton, Hampshire, UK). Transfection was carried out using siPORT Amine siRNA transfection reagent (Ambion, Warrington, UK) following the manufacturer's instructions as described previously 23. After transfection, cells were cultured in a normal cell culture environment for 48 h before further experimentation.…”
Section: Methodsmentioning
confidence: 99%
“…A universal negative control siRNA was used as a negative control (Eurogentec, Southampton, Hampshire, UK). Transfection was carried out using siPORT Amine siRNA transfection reagent (Ambion, Warrington, UK) following the manufacturer's instructions as described previously 23. After transfection, cells were cultured in a normal cell culture environment for 48 h before further experimentation.…”
Section: Methodsmentioning
confidence: 99%
“…Progastrin growth-promoting effects are mediated through the activation of several key signal transduction pathways (21,22). In addition, several works including ours showed that depletion of endogenous progastrin produced by colon cancer cells leads to an inhibition of tumor growth (23,24). Moreover, high concentrations of progastrin are found in colon tumors and in blood of 80% of patients with colorectal cancer.…”
Section: Introductionmentioning
confidence: 99%
“…When combined with gemcitabine, a newer orally active gastrin receptor antagonist (Z-360) has shown modest efficacy against orthotopic pancreatic tumors in mice 30. Transient knockdown of gastrin gene expression by transfecting pancreatic cancer cells with antisense gastrin constructs 31 or with gastrin siRNA 32 decreased gastrin levels and tumor cell proliferation in vitro .…”
Section: Introductionmentioning
confidence: 99%